ML28570 OSCAR 1

• Research type

  Research Study

• Full title

  An observational study of avastin® (bevacizumab) as first line therapy in patients with advanced ovarian cancer

• IRAS ID

  111987

• Contact name

  Marcia Hall

• Contact email

  marcia.hall@nhs.net

• Sponsor organisation

  Roche Products Ltd

• REC name

  London - Brighton & Sussex Research Ethics Committee

• REC reference

  12/LO/1680

• Date of REC Opinion

  21 Dec 2012

• REC opinion

  Further Information Favourable Opinion